Medi Caps Hits 52-Week Low at Rs. 35.7 Amid Market Struggles

Medi Caps, a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week low of Rs. 35.7 today, September 24, 2025. This decline marks a notable underperformance, with the stock down 11.22% during intraday trading and trailing the sector by 5.95%.
The stock has exhibited high volatility, with an intraday volatility rate of 5.78%. Medi Caps is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. Over the past year, the stock has seen a decline of 28.20%, contrasting sharply with the Sensex's relatively modest drop of 3.76%.

Financial metrics reveal ongoing challenges for the company, including operating losses and a weak ability to service its debt, highlighted by a negative EBIT to Interest ratio of -0.91. The latest quarterly results show a significant drop in profit after tax, falling to Rs. -3.49 crore, alongside a 31.34% decrease in net sales over the last six months. These factors contribute to a challenging market position for Medi Caps as it navigates a difficult financial landscape.